Continuous glucose monitoring in children with type 1 diabetes: Before and after insulin pump therapy

Pediatric Diabetes

Volumn 5, Issue 1, 2004, Pages 10-15

  Heptulla, Rubina A ^a   Allen, Holley F ^b   Gross, Todd M ^c   Reiter, Edward O ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c MEDTRONIC INC   (United States)

Author keywords

Blood glucose selfmonitoring; Diabetes mellitus; Hyperglycemia; Hypoglycemia; Infusion systems; Insulin; Insulin dependent diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; ATTENUATION; BLOOD GLUCOSE MONITORING; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MALE; MEAL; MEDICAL RECORD; POSTPRANDIAL STATE; PRIORITY JOURNAL; SCHOOL CHILD; SENSOR; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MONITORING, AMBULATORY; POSTPRANDIAL PERIOD;

EID: 1842865714     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-543X.2004.00035.x     Document Type: Article

References (20)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. Boland E, Grey M, Oesterle A, Fredrickson L, Tamborlane W. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999: 22: 1779-1784.
3. Pickup JC, Keen H, Stevenson RW et al. Insulin via continuous subcutaneous infusion. Lancet 1978: 2: 988-989.
4. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979: 300: 573-578.
5. Hinde FR, Standen PJ, Mann NP, Johnston DI. Seasonal variation of haemoglobin A1 in children with insulin-dependent diabetes mellitus [see comments]. Eur J Pediatr 1989: 148: 597-599.
6. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001: 24: 1858-1862.
7. Porter PA, Keating B, Byrne G, Jones TW. Incidence and predictive criteria of nocturnal hypoglycemia. in young children with insulin-dependent diabetes mellitus. J Pediatr 1997: 130: 366-372.
8. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999: 46: 183-190.
9. Chase HP, Roberts MD, Wightman C et al. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 2003: 111: 790-794.
10. Mastrototaro J. The MiniMed Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 1999: 12 (Suppl. 3): 751-758.
11. HILL RP, Hindle EJ, Howey JE, Lemon M, Lloyd DR. Recommendations for adopting standard conditions and analytical procedures in the measurement of serum fructosamine concentration. Ann Clin Biochem 1990: 27: 413-424.
12. Kaufman FR, Halvorson M, Carpenter S, Devoe D, Pitukcheewanont P. Pump therapy for children: weighing the risks and benefits: view 2: insulin pump therapy in young children with diabetes. Diabetes Spectrum 2001: 14: 84-89.
13. Simonson DC, Tamborlane WV, Defronzo RA, Sherwin RS. Intensive insulin therapy reduces counter-regulatory hormone responses to hypoglycemia in patients with type 1 diabetes. Ann Intern Med 1985: 103: 184-190.
14. Pickup JC, Sherwin RS, Tamborlane WV, Rizza RA, Service FJ. Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems. Diabetes 1985: 34: 37-41.
15. Buckingham B, Beck R, Tamborlane W et al. Diabetes Research in Children Network (DirecNet) Accuracy Study of the Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2™ Biographer (GWB) in Children with Type 1 Diabetes-A CRC-Based Study. New Orleans, LA: 63rd Scientific Session American Diabetes Association, 2003.
16. Simonson DC, Tamborlane WV, Sherwin RS, Smith JD, Defronzo RA. Improved insulin sensitivity in patients with type 1 diabetes mellitus after CSII. Diabetes 1985: 34 (Suppl. 3): 80-86.
17. Bolli GB, Fanelli CG. Physiology of glucose counter regulation to hypoglycemia [review]. Endocrinol Metab Clin North Am 1999: 28: 467-493.
18. Bolli GB. Physiological insulin replacement in type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2001: 109 (Suppl. 2): S317-S332.
19. Bastyr III EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group. Diabetes Care 2000: 23: 1236-1241.
20. American Diabetic Association. Postprandial blood glucose. Diabetes Care 2001: 24: 775-778.